Avid Bioservices Sees FY25 Revenue $160M-$168M vs $164M Est.
Portfolio Pulse from Benzinga Newsdesk
Avid Bioservices has projected its FY25 revenue to be between $160 million and $168 million, compared to the estimated $164 million.
July 02, 2024 | 8:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Avid Bioservices has projected its FY25 revenue to be between $160 million and $168 million, which is in line with the estimated $164 million.
The revenue projection is close to the market estimate, suggesting stability in the company's financial outlook. This is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100